About Journal

Journal of Cancer Research and Clinical Practice (JCRCP) is an International Peer-reviewed Double-Blind Open Access Journal that aims to promote present clinical research on oncology that may play a significant role in the prevention and cure of large families of Cancer and updates recent studies related to Clinical practice of Cancer Science, Cancer Surgery and Therapy.

JCRCP Deals With Research Pertaining To Different Types Of Cancer Such As Prostate Cancer, Bladder Cancer, Bone Cancer, Blood Cancer, Brain Cancer, Cervical Cancer, Ovarian Cancer, Breast Cancer, Renal Cancer, Endocrine Cancer, HPV-Associated Cancer, Head And Neck Cancer, Oral Cancer, Colorectal Cancer, Gastric Cancer, Pancreatic Cancer, Skin Cancer, Lung Cancer, and Esophageal Cancer.

Pubtexto Journal Of Cancer Research And Clinical Practice Devoted To The Publication Of Papers In The Field Of Cancer Research Includes Cancer Science, Cancer Surgery & Therapy, Types Of Cancer, Diagnostic Biomarkers, Malignant Progression, Drug Sensitivity And Resistance, Resistance To Treatment, Novel Methods, Chemotherapy, Radiation Therapy, Etc.

Pubtexto Journal of Cancer Research and Clinical Practice has dealt with an ideal editorial board comprised of acclaimed scientists from across the globe. Each article is subjected to a rigorous peer review. The journal maintains the highest standards in terms of quality and originality. In addition to Research Articles, the Journal also publishes high-quality Perspectives, Commentaries, and Reviews to ensure healthy debates among its readers, describing original research in the fields of basic, translational and clinical cancer research.

Journal of Cancer Research and Clinical Practice (JCRCP) follows a rapid review process and welcomes the direct submission of articles from global authors. 

Submit your manuscript online portal

Plagiarism Policy

The articles submitted by authors must contain a minimum of 80% unique content (Which should be unique and must not copy from any other websites). The authors must maintain 100% uniqueness in the text’s results and conclusion. We will resend the articles, which have below 80% uniqueness to the authors for revision and asked for resubmissions with uniqueness (as per guidelines).

Benefits to authors

We provide many author benefits, such as free PDFs, a liberal copyright policy, social media, and social media optimization that improve citations and help readers h potential collaborators, and correspondents with a platform to publish their research work and update the recent advances.

Review Process: Double-blinded peer review process